Epigenetic activation of SOX11 is associated with recurrence and progression of DCIS to invasive breast cancer
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 54 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 54 samples: 50 distinct titles, 2 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed expression table (series matrix) and the array files, from NCBI.
- Paper
- Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerBritish journal of cancer · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE214094_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA883755 and SRA study SRP398735. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 3 samples read as cases, 3 as controls.
How we read this: Read from 54 sample titles: 50 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM6597260 SUM225, Control rep 1
- GSM6597261 SUM225, Control rep 2
- GSM6597262 SUM225, Control rep 3
- GSM6597263 SUM225, Treated rep 1
- GSM6597264 SUM225, Treated rep 2
- GSM6597265 SUM225, Treated rep 3
- GSM6598900 DCIS-01T
- GSM6598901 DCIS-02T
- GSM6598902 DCIS-03T
- GSM6598903 DCIS-04T
- GSM6598904 DCIS-05T
- GSM6598905 DCIS-06T
- GSM6598906 DCIS-07T
- GSM6598907 DCIS-08T
- GSM6598908 DCIS-09T
- GSM6598909 DCIS-10T
- GSM6598910 DCIS-11T
- GSM6598911 DCIS-12T
- GSM6598912 DCIS-13T
- GSM6598913 DCIS-14T
- GSM6598914 DCIS-15T
- GSM6598915 DCIS-16T
- GSM6598916 DCIS-17T
- GSM6598917 DCIS-18T
- GSM6598918 DCIS-19T
- GSM6598919 DCIS-20T
- GSM6598920 DCIS-21T
- GSM6598921 DCIS-22T
- GSM6598922 DCIS-23T
- GSM6598923 DCIS-24T
- GSM6598924 DCIS-25T
- GSM6598925 DCIS-26T
- GSM6598926 DCIS-27T
- GSM6598927 DCIS-28T
- GSM6598928 DCIS-29T
- GSM6598929 DCIS-30T
- GSM6598930 DCIS-31T
- GSM6598931 DCIS-32T
- GSM6598932 DCIS-33T
- GSM6598933 DCIS-34T
+ 14 more — browse all 54 samples with per-sample file links →
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares activation, breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares progression, breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE304097 DNA methylation profiling identifies long-range epigenetic silencing of clustered protocadherins as a key determinant of meningioma progression 293 samples shares progression, epigenetic
- GSE289044 Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression 252 samples shares progression, invasive
- GSE274680 Inflammation and lymphocyte activation during longitudinal progression to rheumatoid arthritis in at-risk individuals 243 samples shares progression, activation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.